首页> 外国专利> METHOD FOR MORPHOMETRIC ESTIMATION OF THE PROGNOSIS OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BY THE INDEX OF THE PROPORTION OF TUMOUR CELLS EXPRESSING PSTAT3 AND PAKT1 IN LYMPH NODES

METHOD FOR MORPHOMETRIC ESTIMATION OF THE PROGNOSIS OF THE COURSE OF DIFFUSE LARGE B-CELL LYMPHOMA BY THE INDEX OF THE PROPORTION OF TUMOUR CELLS EXPRESSING PSTAT3 AND PAKT1 IN LYMPH NODES

机译:通过淋巴结中表达PSTAT3和PAKT1的肿瘤细胞比例指数对弥漫性大B细胞淋巴瘤病程预后进行形态计量学评估的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to the field of medicine, particularly to hematology and oncology. To predict the course of diffuse large B-cell lymphoma (DLBCL), after lymphadenectomy, immunohistochemical analysis is conducted on slices of lymph nodes with antibodies against pSTAT3 and pAKT1. The relative amount of tumour cells expressing pSTAT3 and pAKT1 is calculated by the formula: S1=D1/n × 100%, wherein S1 is the proportion of pSTAT3 positive cells in the lymph node (%), D1 is the average amount of pSTAT3 positive cells in 10 fields of view, n is the total amount of cells in 10 fields of view; S2=D2/n × 100%, wherein S2 is the proportion of pAKT1 positive cells in the lymph node (%), D2 is the average amount of pAKT1 positive elements in 10 fields of view, n is the total amount of cells in 10 fields of view. The proportion index (PI) is determined by the formula, %: PI =(S1+S2)/2. At PI values less than 70%, a favourable course of DLBCL, and at values of 70% or greater, an unfavourable outcome of the disease is predicted.;EFFECT: method is informative and can be used in hematology and pathology departments, pathomorphological laboratories as an additional criterion for predicting the course of DLCCL.;1 cl, 2 ex
机译:领域:医学。;物质:本发明涉及医学领域,尤其涉及血液学和肿瘤学。为了预测弥漫性大B细胞淋巴瘤(DLBCL)的病程,在淋巴结切除术后,对带有pSTAT3和pAKT1抗体的淋巴结切片进行免疫组织化学分析。表达pSTAT3和pAKT1的肿瘤细胞的相对数量通过以下公式计算:S1=D1/n×100%,其中S1是淋巴结中pSTAT3阳性细胞的比例(%),D1是10个视野中pSTAT3阳性细胞的平均数量,n是10个视野中的细胞总数;S2=D2/n×100%,其中S2为淋巴结中pAKT1阳性细胞的比例(%),D2为10个视野中pAKT1阳性元素的平均数量,n为10个视野中的细胞总数。比例指数(PI)由公式(%:PI=(S1+S2)/2确定。当PI值小于70%时,DLBCL的病程是有利的,当PI值大于或等于70%时,疾病的预后是不利的。;效果:该方法信息丰富,可用于血液学和病理学部门、病理形态学实验室,作为预测DLCCL病程的附加标准。;1 cl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号